Publication Name	World Journal of Gastroenterology
Manuscript ID	63529
Country	United States

Received	2021-01-28 23:24
Peer-Review Started	2021-01-28 23:29
To Make the First Decision
Return for Revision	2021-03-06 06:38
Revised	2021-03-20 12:27
Second Decision	2021-07-13 03:33
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-07-13 08:08
Articles in Press	2021-07-13 08:08
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-07-30 08:07
Publish the Manuscript Online	2021-08-04 07:56

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years
Manuscript Source	Invited Manuscript
All Author List	Brittany B Dennis, Leen Naji, Yasmin Jajarmi, Aijaz Ahmed and Donghee Kim
Funding Agency and Grant Number
Corresponding Author	Donghee Kim, MD, PhD, N/A, N/A, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, 300 Pasteur Drive, Palo Alto, CA 94034, United States. dhkimmd@stanford.edu
Key Words	Hepatitis C virus; Direct-acting antivirals; Global health; Liver transplantation; People who inject drugs; Liver cirrhosis
Core Tip	Hepatitis C virus (HCV) is a global health concern associated with significant morbidity and mortality. The introduction of well-tolerated oral direct-acting antiviral agents in late 2013 has revolutionized HCV management with over 90% cure rates. Equitable access to these agents remains an important issue, given that countries with the greatest burden of disease have the least access to curative therapies. Here we provide a literature review of HCV, changes in epidemiologic trends, current therapies, and highlight inequities in the burden of disease and access to treatment.
Publish Date	2021-08-04 07:56
Citation	Dennis BB, Naji L, Jajarmi Y, Ahmed A, Kim D. New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years. World J Gastroenterol 2021; 27(29): 4818-4830
URL	https://www.wjgnet.com/1007-9327/full/v27/i29/4818.htm
DOI	https://dx.doi.org/10.3748/wjg.v27.i29.4818

Full Article (PDF)	WJG-27-4818.pdf
Full Article (Word)	WJG-27-4818.docx
Manuscript File	63529_Auto_Edited-JPY.docx
Answering Reviewers	63529-Answering reviewers.pdf
Audio Core Tip	63529-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	63529-Conflict-of-interest statement.pdf
Copyright License Agreement	63529-Copyright license agreement.pdf
Peer-review Report	63529-Peer-review(s).pdf
Scientific Misconduct Check	63529-Bing-Wang JL-1.jpg
Scientific Misconduct Check	63529-Bing-Fan JR-2.png
Scientific Misconduct Check	63529-Scientific misconduct check.pdf
Scientific Editor Work List	63529-Scientific editor work list.pdf
CrossCheck Report	63529-CrossCheck report.pdf
CrossCheck Report	63529-CrossCheck.png